AAAAAA
Results:
1-25
|
Results: 25
Authors:
Beresford, N
Seymour, L
Vincent, C
Moat, N
Citation: N. Beresford et al., Risks of elective cardiac surgery: what do patients want to know?, HEART, 86(6), 2001, pp. 626-631
Authors:
Chung-Faye, G
Palmer, D
Anderson, D
Clark, J
Downes, M
Baddeley, J
Hussain, S
Murray, PI
Searle, P
Seymour, L
Harris, PA
Ferry, D
Kerr, DJ
Citation: G. Chung-faye et al., Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: A phase I and pharmacokinetic study of its prodrug, CB1954, CLIN CANC R, 7(9), 2001, pp. 2662-2668
Authors:
Berry, M
Gonzalez, AM
Clarke, W
Greenlees, L
Barrett, L
Tsang, W
Seymour, L
Bonadio, J
Logan, A
Baird, A
Citation: M. Berry et al., Sustained effects of gene-activated matrices after CNS injury, MOL CELL NE, 17(4), 2001, pp. 706-716
Authors:
Knowling, M
Browman, G
Siu, L
Khoo, K
Cooke, A
Tannock, I
Klaassen, D
Cripps, C
Goss, G
Matthews, S
Clarke, R
Seymour, L
Citation: M. Knowling et al., A National Cancer Institute of Canada Clinical Trials Group phase II studyof eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer, ANN ONCOL, 12(7), 2001, pp. 919-922
Authors:
Taylor, RL
Seymour, L
Chen, YP
Citation: Rl. Taylor et al., Weak laws of large numbers for fuzzy random sets, NONLIN ANAL, 47(2), 2001, pp. 1245-1256
Authors:
Seymour, L
Eisenhauer, E
Citation: L. Seymour et E. Eisenhauer, A review of dose-limiting events in phase I trials: antimetabolites show unpredictable relationships between dose and toxicity, CANC CHEMOT, 47(1), 2001, pp. 2-10
Authors:
Seymour, L
Bezwoda, WR
Citation: L. Seymour et Wr. Bezwoda, Sequential alpha-interference and tamoxifen: in-vitro reversal of MDR-1 mediated multidrug resistance in the MCF-7 cell line (vol 7, pg 325, 1998), BREAST, 9(3), 2000, pp. 173-173
Authors:
Gertler, SZ
MacDonald, D
Goodyear, M
Forsyth, P
Stewart, DJ
Belanger, K
Perry, J
Fulton, D
Steward, W
Wainman, N
Seymour, L
Citation: Sz. Gertler et al., NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94), ANN ONCOL, 11(3), 2000, pp. 315-318
Authors:
Hirte, H
Goel, R
Major, P
Seymour, L
Huan, S
Stewart, D
Yau, J
Arnold, A
Holohan, S
Waterfield, B
Bates, S
Bennett, K
Walsh, W
Elias, I
Citation: H. Hirte et al., A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours, ANN ONCOL, 11(12), 2000, pp. 1579-1584
Authors:
Choo, S
Seymour, L
Morris, R
Quataert, S
Lockhart, S
Cartwright, K
Finn, A
Citation: S. Choo et al., Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine inUnited Kingdom infants, PEDIAT INF, 19(9), 2000, pp. 854-862
Authors:
Vanderkerken, S
Vanheede, T
Toncheva, V
Schacht, E
Wolfert, MA
Seymour, L
Urtti, A
Citation: S. Vanderkerken et al., Synthesis and evaluation of poly(ethylene glycol)-polylysine block copolymers as carriers for gene delivery, J BIOACT C, 15(2), 2000, pp. 115-138
Authors:
Seymour, L
Citation: L. Seymour, FEMA: 87,000 structures threatened by erosin, ARCHITECTUR, 89(9), 2000, pp. 33-34
Authors:
Seymour, L
Mockbee, S
Citation: L. Seymour et S. Mockbee, Samuel Mockbee: Reluctant genius - Rural-Studio cofounder receives MacArthur Fellowship (An interview), ARCHITECTUR, 89(8), 2000, pp. 27-28
Authors:
Seymour, L
Citation: L. Seymour, Disney loses $240M judgment to Canadian architect, partner (Edward Russelland Nicholas Stracick of All-Pro-Sports-Camps cite similarities between their proposed sports complex and Disney's Wide-World-of-Sports theme park), ARCHITECTUR, 89(10), 2000, pp. 36-36
Authors:
Hoste, K
Schacht, E
Seymour, L
Citation: K. Hoste et al., New derivatives of polyglutamic acid as drug carrier systems, J CONTR REL, 64(1-3), 2000, pp. 53-61
Authors:
Choo, S
Zhang, QB
Seymour, L
Akhtar, S
Finn, A
Citation: S. Choo et al., Primary and booster salivary antibody responses to a 7-valent pneumococcalconjugate vaccine in infants, J INFEC DIS, 182(4), 2000, pp. 1260-1263
Authors:
Seymour, L
Citation: L. Seymour, Margot Fonteyn, DANCING TIM, 90(1076), 2000, pp. 696-697
Authors:
Seymour, L
Citation: L. Seymour, Rudollph (Remembering Rudolph Nureyev), DANCING TIM, 90(1075), 2000, pp. 605
Authors:
Seymour, L
Citation: L. Seymour, Remembering Christopher Gable, DANCING TIM, 90(1074), 2000, pp. 503
Authors:
Seymour, L
Citation: L. Seymour, Ballet education - Are we forgetting fundamentals?, DANCING TIM, 90(1072), 2000, pp. 313-313
Authors:
van Iersel, MW
Seymour, L
Citation: Mw. Van Iersel et L. Seymour, Growth respiration, maintenance respiration, and carbon fixation of vinca:A time series analysis, J AM S HORT, 125(6), 2000, pp. 702-706
Authors:
Armand, JP
Seymour, L
Evans, TRJ
Citation: Jp. Armand et al., Raltitrexed (Tomudex (TM)) in combination with platinum-based agents and/or anthracyclines: Preliminary results of phase I clinical trials, EUR J CANC, 35, 1999, pp. S14-S18
Authors:
Moore, MJ
Winquist, EW
Murray, N
Tannock, IF
Huan, S
Bennett, K
Walsh, W
Seymour, L
Citation: Mj. Moore et al., Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada clinical trials group, J CL ONCOL, 17(9), 1999, pp. 2876-2881
Authors:
Seymour, L
Bezwoda, WR
Citation: L. Seymour et Wr. Bezwoda, Sequential alpha-interferon and tamoxifen: in-vitro reversal of MDR-1 mediated multidrug resistance in the MCF-7 cell line, BREAST, 7(6), 1998, pp. 325-331
Authors:
Zalcberg, J
Kerr, D
Seymour, L
Palmer, M
Citation: J. Zalcberg et al., Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number, EUR J CANC, 34(12), 1998, pp. 1871-1875
Risultati:
1-25
|